Proton Pump Inhibitors Do Not Affect the Bioavailability of a Novel Liquid Formulation of Levothyroxine.
Saved in:
| Title: | Proton Pump Inhibitors Do Not Affect the Bioavailability of a Novel Liquid Formulation of Levothyroxine. |
|---|---|
| Authors: | Seng Yue C; Learn and Confirm Inc, Montreal, Canada., Scarsi C; IBSA Institut Biochimique SA, Lugano, Switzerland., Bettazzi E; IBSA Institut Biochimique SA, Lugano, Switzerland., Mautone G; IBSA Institut Biochimique SA, Lugano, Switzerland., Celi FS; Department of Medicine at University of Connecticut Health, Farmington, Connecticut., Ducharme M; University of Montreal, Montreal, Canada. Electronic address: murray.ducharme@learnandconfirm.ca. |
| Source: | Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists [Endocr Pract] 2024 Jun; Vol. 30 (6), pp. 513-520. Date of Electronic Publication: 2024 Mar 28. |
| Publication Type: | Comparative Study; Journal Article; Randomized Controlled Trial |
| Journal Info: | Publisher: Elsevier Inc Country of Publication: United States NLM ID: 9607439 Publication Model: Print-Electronic Cited Medium: Print ISSN: 1530-891X (Print) Linking ISSN: 1530891X NLM ISO Abbreviation: Endocr Pract Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
